Olga Dolgikh

Mrs. Olga Dolgikh

Research Centre for Medical Genetics
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
VSVasilina Sergeeva
Vasilina Sergeeva
OKOlga Kraevaya
Olga Kraevaya
EEElizaveta Ershova
Elizaveta Ershova
LKLarisa Kameneva
Larisa Kameneva
EMElena Mikhailovna Malinovskaya
Elena Mikhailovna Malinovskaya
SKSvetlana Kostyuk
Svetlana Kostyuk
Oxidative stress is a major issue in a wide number of pathologies (neurodegenerative, cardiovascular, immune diseases, and cancer). Because of this, the search for new antioxidants is an important issue. One of the potential antioxidants that has been enthusiastically discussed in the past twenty years is fullerene and its derivatives. Although in aqueous solutions fullerene derivatives have shown to be antioxidants, their properties in this regard within the cells are controversially discussed. We have studied two different water-soluble fullerene C60 and C70 derivatives on human embryonic lung fibroblasts at a wide range of concentrations. Both of them cause a decrease in cellular ROS at short times of incubation (1 hour). Their prolonged action, however, is fundamentally different: derivative GI-761 causes secondary oxidative stress whereas derivative VI-419-P3K keeps ROS levels under control values. To gain a better understanding of this effect, we assessed factors that could play a role in the response of cells to fullerene derivatives. Increased ROS production occurred due to NOX4 upregulation by GI-761. Derivative VI-419-P3K activated the transcription of antioxidant master regulator NRF2 and caused its translocation to the nucleus. This data suggests that the antioxidant effect of fullerene derivatives depends on their chemical structure.

8 December 2016 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
EEElizaveta Ershova
Elizaveta Ershova
EJE.M. Jestkova
E.M. Jestkova
ICI.V. Chestkov
I.V. Chestkov
Lev N. PorokhovnikLev N. Porokhovnik
Lev N. Porokhovnik
VIV.L. Izevskaya
V.L. Izevskaya
SKS.V. Kostyuk
S.V. Kostyuk

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
VSV A Sergeeva
V A Sergeeva
EEElizaveta Ershova
Elizaveta Ershova
NVN N Veiko
N N Veiko
EMElena Mikhailovna Malinovskaya
Elena Mikhailovna Malinovskaya
AKA A Kalyanov
A A Kalyanov
SKS V Kostyuk
S V Kostyuk
We have hypothesized that the adaptive response to low doses of ionizing radiation (IR) is mediated by oxidized cell‐free DNA (cfDNA) fragments. Here, we summarize our experimental evidence for this model. Studies involving measurements of ROS, expression of the NOX (superoxide radical production), induction of apoptosis and DNA double‐strand breaks, antiapoptotic gene expression and cell cycle inhibition confirm this hypothesis. We have demonstrated that treatment of mesenchymal stem cells (MSCs) with low doses of IR (10 cGy) leads to cell death of part of cell population and release of oxidized cfDNA. cfDNA has the ability to penetrate into the cytoplasm of other cells. Oxidized cfDNA, like low doses of IR, induces oxidative stress, ROS production, ROS‐induced oxidative modifications of nuclear DNA, DNA breaks, arrest of the cell cycle, activation of DNA reparation and antioxidant response, and inhibition of apoptosis. The MSCs pretreated with low dose of irradiation or oxidized cfDNA were equally effective in induction of adaptive response to challenge further dose of radiation. Our studies suggest that oxidized cfDNA is a signaling molecule in the stress signaling that mediates radiation‐induced bystander effects and that it is an important component of the development of radioadaptive responses to low doses of IR.

16 July 2020 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
GSGalina Shmarina
Galina Shmarina
EEElizaveta S. Ershova
Elizaveta S. Ershova
NSNatalia V. Simashkova
Natalia V. Simashkova
SNSvetlana G. Nikitina
Svetlana G. Nikitina
JCJulia M. Chudakova
Julia M. Chudakova
SKSvetlana V. Kostyuk
Svetlana V. Kostyuk
Background: Autism spectrum disorders (ASD) are known to be associated with an inflammatory process related to immune system dysfunction. This study’s aim was to investigate the role of cell-free DNA in chronic inflammatory process in ASD patients. Methods: The study included 133 ASD patients and 27 healthy controls. Sixty-two ASD patients were demonstrated to have mild-to-moderate disease severity (group I) and 71 individuals to have severe ASD (group II). Plasma cell-free (cf) DNA characteristics, plasma cytokine concentrations, expression of the genes for NFкB1 transcription factor and pro-inflammatory cytokines TNFα, IL-1β and IL-8 in peripheral blood lymphocytes (PBL) of ASD patients, and unaffected controls were investigated. Additionally, in vitro experiments with oxidized DNA supplementation to PBL cultures derived from ASD patients and healthy controls were performed. Results: The data indicates that ASD patients have demonstrated increased cfDNA concentration in their circulation. cfDNA of patients with severe ASD has been characterized by a high abundance of oxidative modification. Furthermore, ASD patients of both groups have shown elevated plasma cytokine (IL-1β, IL-8, IL-17A) levels and heightened expression of genes for NFкB1 nuclear factor and pro-inflammatory cytokines TNFα, IL-1β, and IL-8 in PBL. In vitro experiments have shown that NF-κB/cytokine mRNA expression profiles of ASD patient PBL treated with oxidized DNA fragments were significantly different from those of healthy controls. Conclusions: It may be proposed that oxidized cfDNA plays a role of stress-signaling factor activating the chronic inflammatory process in patients with ASD.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ICI V Chestkov
I V Chestkov
EJE M Jestkova
E M Jestkova
EEElizaveta Ershova
Elizaveta Ershova
VGV G Golimbet
V G Golimbet
TLT V Lezheiko
T V Lezheiko
SKS V Kostyuk
S V Kostyuk
Objective. The aim of this study was (1) to examine the leukocyte mtDNA copy number (CN) in unmedicated (SZ (m−)) and medicated (SZ (m+)) male patients with paranoid schizophrenia (SZ) in comparison with the healthy male controls (HC) and (2) to compare the leukocyte mtDNA CN with the content of an oxidation marker 8‐oxodG in lymphocytes of the SZ (m−) patients. Methods. We evaluated leukocyte mtDNA CN of 110 subjects with SZ in comparison with 60 male HC by the method qPCR (ratio mtDNA/nDNA (gene B2M) was detected). SZ patients were divided into two subgroups. The patients of the subgroups SZ (m+) (N = 55) were treated with standard antipsychotic medications in the hospital. The patients of the subgroup SZ (m−) (N = 55) were not treated before venous blood was sampled. To evaluate oxidative DNA damage, we quantified the levels of 8‐oxodG in lymphocytes (flow cytometry) of SZ (m−) patients (N = 55) and HC (N = 30). Results. The leukocyte mtDNA CN showed no significant difference in SZ (m+) patients and HC. The mtDNA CN in the unmedicated subgroup SZ (m−) was significantly higher than that in the SZ (m+) subgroup or in HC group. The level of 8‐oxodG in the subgroup SZ (m−) was significantly higher than that in HC group. Conclusion. The leukocytes of the unmedicated SZ male patients with acute psychosis contain more mtDNA than the leukocytes of the male SZ patients treated with antipsychotic medications or the healthy controls. MtDNA content positively correlates with the level of 8‐oxodG in the unmedicated SZ patients.

8 July 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
AFAnton Filev
Anton Filev
GSGalina Shmarina
Galina Shmarina
EEE. S. Ershova
E. S. Ershova
NVN. N. Veiko
N. N. Veiko
AMA. V. Martynov
A. V. Martynov
PUPavel Umriukhin
Pavel Umriukhin
The present study focuses on the investigation of the oxidized cell-free DNA (cfDNA) properties in several experimental models, including cultured cerebellum cells, peripheral blood lymphocytes (PBL), plasma, and hippocampus under an acute and chronic unpredictable stress model in rats. Firstly, our study shows that Spectrum Green fluorescence-labeled oxidized cfDNA fragments were transferred into the cytoplasm of 80% of the cerebellum culture cells; meanwhile, the nonoxidized cfDNA fragments do not pass into the cells. Oxidized cfDNA stimulates the antioxidant mechanisms and induction of transcription factor NRF2 expression, followed by an activation of NRF2 signaling pathway genes—rise of Nrf2 and Hmox1 gene expression and consequently NRF2 protein synthesis. Secondly, we showed that stress increases plasma cfDNA concentration in rats corresponding with the duration of the stress exposure. At the same time, our study did not reveal any significant changes of 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) level in PBL of rats under acute or chronic stress, probably due to the significantly increased Nrf2 expression, that we found in such conditions. 8-oxodG is one of the most reliable markers of DNA oxidation. We also found an increased level of 8-oxodG in the hippocampal homogenates and hippocampal dentate gyrus in rats subjected to acute and chronic stress. Taken together, our data shows that oxidized cfDNA may play a significant role in systemic and neuronal physiological mechanisms of stress and adaptation.